tiprankstipranks
Trending News
More News >

Futura Medical Strengthens Governance with AGM Resolutions

Story Highlights
Futura Medical Strengthens Governance with AGM Resolutions

Don’t Miss TipRanks’ Half-Year Sale

Futura Medical ( (GB:FUM) ) has issued an update.

Futura Medical announced the successful passing of all resolutions at its recent Annual General Meeting, including the appointment and re-election of directors and the re-appointment of its auditor. This development is expected to strengthen the company’s governance and operational framework. The company continues to focus on expanding its market presence with its innovative sexual health products, supported by strategic partnerships in major markets such as the US and Europe.

The most recent analyst rating on (GB:FUM) stock is a Buy with a £125.00 price target. To see the full list of analyst forecasts on Futura Medical stock, see the GB:FUM Stock Forecast page.

More about Futura Medical

Futura Medical plc is a consumer healthcare company specializing in the development and global commercialization of innovative and clinically proven sexual health products. Its core strength lies in research, development, and commercialization of topically delivered gel formulations, with key products including Eroxon, WSD4000, and Eroxon Intense. The company addresses significant unmet needs in the sexual health market, particularly with its lead product, Eroxon, which is the only topical gel treatment for erectile dysfunction available over the counter.

Average Trading Volume: 484,727

Technical Sentiment Signal: Sell

Current Market Cap: £27.19M

For detailed information about FUM stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1